ALS Drug Development Summit

May 12-14, 2025
Boston, MA

The 4th Annual ALS Drug Development Summit 2025, taking place from May 12-14 in Boston, MA, will bring together scientific leaders to address the most pressing challenges in ALS and FTD therapy development. With the rapid evolution of ALS research, this summit explores innovative mechanistic targets like STMN2, UNC13A, and neuroinflammation, alongside advancements in precision biomarkers such as TDP-43 PET tracers and NFL. Experts will discuss cutting-edge clinical trial designs, focusing on adaptive and decentralized strategies that prioritize inclusivity and reduce patient burden.

PRC Clinical, a leading CRO in ALS clinical development, is engaging with industry leaders to share insights on optimizing operations and enhancing the quality of study data in ALS and FTD clinical trials. Whether you are preparing for a first-in-human study or a pivotal trial, meet with PRC Clinical’s senior management to discuss how we can efficiently manage your next ALS or FTD clinical trial. Fill out the form below to schedule a discussion.

View the Conference Website